Moderna
MRNA
#1251
Rank
โ‚น1.756 T
Marketcap
โ‚น4,427
Share price
-4.97%
Change (1 day)
96.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น280.77 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.20 Billion. In 2025 the company made an earning of -โ‚น267.03 Billion, an increase over its 2024 earnings that were of -โ‚น346.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น280.77 Billion5.14%
2025 -โ‚น267.03 Billion-23.03%
2024 -โ‚น346.91 Billion-8.22%
2023 -โ‚น377.99 Billion-140.65%
2022 โ‚น929.85 B-27.81%
2021 โ‚น1.287 T-1911.15%
2020 -โ‚น71.12 Billion44.7%
2019 -โ‚น49.15 Billion28.63%
2018 -โ‚น38.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.515 T-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.528 T-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น1.273 T-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.6 Billion-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.4 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น4.05 Billion-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น84.20 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น33.41 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA